Close

Analyst Ratings for Trillium Therapeutics (TRIL) [Buys]

TRIL Rating Summary

  |   Expand Research on TRIL
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5 / 10   Percentile Rank: 53%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
10/12/2020 Evercore ISI N/A New Coverage Outperform
(N/A)
N/A
(N/A)
15.37
(18.44)
19.97% Details
6/19/2020 Jones Trading Soumit Roy New Coverage Buy
(N/A)
15.00
(N/A)
8.23
(18.44)
124.06% Details
Like TRIL Ratings? Also take a look at

TRIL Ratings News